Safety of voriconazole in a patient with CYP2C92/CYP2C92 genotype

Saved in:

Bibliographic Details
Published in:	Antimicrobial agents and chemotherapy Vol. 50; no. 9; pp. 3227 - 3228
Main Authors:	Geist, Marcus J P, Egerer, Gerlinde, Burhenne, Jürgen, Mikus, Gerd
Format:	Journal Article
Language:	English
Published:	United States American Society for Microbiology 01-09-2006
Subjects:	Antifungal Agents Antifungal Agents - pharmacokinetics Aryl Hydrocarbon Hydroxylases Aryl Hydrocarbon Hydroxylases - genetics Aryl Hydrocarbon Hydroxylases - metabolism Commented On Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2C9 Cytochrome P-450 CYP3A Cytochrome P-450 Enzyme System - genetics Cytochrome P-450 Enzyme System - metabolism Genotype Humans Letters to the Editor Mixed Function Oxygenases - genetics Mixed Function Oxygenases - metabolism Pyrimidines Pyrimidines - pharmacokinetics Triazoles Triazoles - pharmacokinetics Voriconazole
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 Phone: 49 6221 56 39197, Fax: 49 6221 56 4642, E-mail: gerd.mikus@med.uni-heidelberg.de
ISSN:	0066-4804 1098-6596
DOI:	10.1128/AAC.00551-06